Oruka Therapeutics Stock Forecast

Stock Price Forecast

The 5 analysts with 12-month price forecasts for Oruka Therapeutics stock have an average target of 43.6, with a low estimate of 40 and a high estimate of 49. The average target predicts an increase of 127.32% from the current stock price of 19.18.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$40	$43.6	$44	$49
Change	+108.55%	+127.32%	+129.41%	+155.47%

Analyst Ratings

The average analyst rating for ORKA stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '24	Oct '24	Nov '24	Dec '24
Strong Buy	2	4	4	4
Buy	2	2	2	2
Hold	0	0	0	0
Sell	0	0	0	0
Strong Sell	0	0	0	0
Total	4	6	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $45	Strong Buy	Reiterates	$45	+134.62%	Dec 20, 2024
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $45	Strong Buy	Reiterates	$45	+134.62%	Nov 25, 2024
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $45	Strong Buy	Reiterates	$45	+134.62%	Oct 31, 2024
Alex Thompson Stifel	Stifel	Strong Buy Initiates $49	Strong Buy	Initiates	$49	+155.47%	Oct 11, 2024
Mitchell Kapoor HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Initiates $45	Strong Buy	Initiates	$45	+134.62%	Oct 7, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

n/a

EPS Next Year

n/a

No financial forecasts available for this stock

Revenue Forecast

No data available

Revenue Growth

No data available

EPS Forecast

No data available

EPS Growth

No data available

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.